Kelun-Biotech's breast cancer drug shows promising phase 3 results
PositiveFinancial Markets

Kelun-Biotech has announced promising results from its phase 3 clinical trial for a new breast cancer drug, which could significantly improve treatment options for patients. This development is crucial as it highlights advancements in cancer therapies, potentially leading to better outcomes and quality of life for those affected by the disease.
— Curated by the World Pulse Now AI Editorial System